These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 27845387)

  • 121. CTLA4Ig delivered by high-capacity adenoviral vector induces stable expression of dystrophin in mdx mouse muscle.
    Jiang Z; Schiedner G; Gilchrist SC; Kochanek S; Clemens PR
    Gene Ther; 2004 Oct; 11(19):1453-61. PubMed ID: 15269713
    [TBL] [Abstract][Full Text] [Related]  

  • 122. The CRISPR Way to Think about Duchenne's.
    Calos MP
    N Engl J Med; 2016 Apr; 374(17):1684-6. PubMed ID: 27119241
    [No Abstract]   [Full Text] [Related]  

  • 123. Restoration of human dystrophin following transplantation of exon-skipping-engineered DMD patient stem cells into dystrophic mice.
    Benchaouir R; Meregalli M; Farini A; D'Antona G; Belicchi M; Goyenvalle A; Battistelli M; Bresolin N; Bottinelli R; Garcia L; Torrente Y
    Cell Stem Cell; 2007 Dec; 1(6):646-57. PubMed ID: 18371406
    [TBL] [Abstract][Full Text] [Related]  

  • 124. Duchenne muscular dystrophy: genome editing gives new hope for treatment.
    Crispi V; Matsakas A
    Postgrad Med J; 2018 May; 94(1111):296-304. PubMed ID: 29386334
    [TBL] [Abstract][Full Text] [Related]  

  • 125. Optimizing antisense oligonucleotides using phosphorodiamidate morpholino oligomers.
    Popplewell LJ; Malerba A; Dickson G
    Methods Mol Biol; 2012; 867():143-67. PubMed ID: 22454060
    [TBL] [Abstract][Full Text] [Related]  

  • 126. Dystrophin gene editing by CRISPR/Cas9 system in human skeletal muscle cell line (HSkMC).
    Dara M; Razban V; Mazloomrezaei M; Ranjbar M; Nourigorji M; Dianatpour M
    Iran J Basic Med Sci; 2021 Aug; 24(8):1153-1158. PubMed ID: 34804433
    [TBL] [Abstract][Full Text] [Related]  

  • 127. Duchenne muscular dystrophy in a female with compound heterozygous contiguous exon deletions.
    Takeshita E; Minami N; Minami K; Suzuki M; Awashima T; Ishiyama A; Komaki H; Nishino I; Sasaki M
    Neuromuscul Disord; 2017 Jun; 27(6):569-573. PubMed ID: 28434908
    [TBL] [Abstract][Full Text] [Related]  

  • 128. Intravenous infusion of an antisense oligonucleotide results in exon skipping in muscle dystrophin mRNA of Duchenne muscular dystrophy.
    Takeshima Y; Yagi M; Wada H; Ishibashi K; Nishiyama A; Kakumoto M; Sakaeda T; Saura R; Okumura K; Matsuo M
    Pediatr Res; 2006 May; 59(5):690-4. PubMed ID: 16627883
    [TBL] [Abstract][Full Text] [Related]  

  • 129. Adenine base editing in mouse embryos and an adult mouse model of Duchenne muscular dystrophy.
    Ryu SM; Koo T; Kim K; Lim K; Baek G; Kim ST; Kim HS; Kim DE; Lee H; Chung E; Kim JS
    Nat Biotechnol; 2018 Jul; 36(6):536-539. PubMed ID: 29702637
    [TBL] [Abstract][Full Text] [Related]  

  • 130. Genetic polymorphism in muscle biopsies of Duchenne and Becker muscular dystrophy patients.
    Anand A; Prabhakar S; Kaul D
    Neurol India; 1999 Sep; 47(3):218-23. PubMed ID: 10514583
    [TBL] [Abstract][Full Text] [Related]  

  • 131. [Correlation between genotypes and phenotypes in pseudohypertrophic muscular dystrophy].
    Feng SW; Liang YY; Cao JQ; Song XM; Zhang C
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Dec; 29(6):653-7. PubMed ID: 23225043
    [TBL] [Abstract][Full Text] [Related]  

  • 132. [Nonsense readthrough therapy for Duchenne muscular dystrophy].
    Takeshima Y
    Rinsho Shinkeigaku; 2014; 54(12):1074-6. PubMed ID: 25672712
    [TBL] [Abstract][Full Text] [Related]  

  • 133. Intragenic deletions in the dystrophin gene in 211 Pakistani Duchenne muscular dystrophy patients.
    Hassan MJ; Mahmood S; Ali G; Bibi N; Waheed I; Rafiq MA; Ansar M; Ahmad W
    Pediatr Int; 2008 Apr; 50(2):162-6. PubMed ID: 18353051
    [TBL] [Abstract][Full Text] [Related]  

  • 134. Mutation spectrum of dystrophin gene in malaysian patients with Duchenne/Becker muscular dystrophy.
    Rani AQ; Sasongko TH; Sulong S; Bunyan D; Salmi AR; Zilfalil BA; Matsuo M; Zabidi-Hussin ZA
    J Neurogenet; 2013 Jun; 27(1-2):11-5. PubMed ID: 23438214
    [TBL] [Abstract][Full Text] [Related]  

  • 135. Human iPSC model reveals a central role for NOX4 and oxidative stress in Duchenne cardiomyopathy.
    Duelen R; Costamagna D; Gilbert G; De Waele L; Goemans N; Desloovere K; Verfaillie CM; Sipido KR; Buyse GM; Sampaolesi M
    Stem Cell Reports; 2022 Feb; 17(2):352-368. PubMed ID: 35090586
    [TBL] [Abstract][Full Text] [Related]  

  • 136. Rescue of dystrophin mRNA of Duchenne muscular dystrophy by inducing exon skipping.
    Matsuo M; Takeshima Y
    Acta Myol; 2005 Oct; 24(2):110-4. PubMed ID: 16550927
    [TBL] [Abstract][Full Text] [Related]  

  • 137. When a mid-intronic variation of DMD gene creates an ESE site.
    Trabelsi M; Beugnet C; Deburgrave N; Commere V; Orhant L; Leturcq F; Chelly J
    Neuromuscul Disord; 2014 Dec; 24(12):1111-7. PubMed ID: 25193336
    [TBL] [Abstract][Full Text] [Related]  

  • 138. Genome Editing Gene Therapy for Duchenne Muscular Dystrophy.
    Hotta A
    J Neuromuscul Dis; 2015 Sep; 2(4):343-355. PubMed ID: 27858753
    [TBL] [Abstract][Full Text] [Related]  

  • 139. Immortalized skin fibroblasts expressing conditional MyoD as a renewable and reliable source of converted human muscle cells to assess therapeutic strategies for muscular dystrophies: validation of an exon-skipping approach to restore dystrophin in Duchenne muscular dystrophy cells.
    Chaouch S; Mouly V; Goyenvalle A; Vulin A; Mamchaoui K; Negroni E; Di Santo J; Butler-Browne G; Torrente Y; Garcia L; Furling D
    Hum Gene Ther; 2009 Jul; 20(7):784-90. PubMed ID: 19358679
    [TBL] [Abstract][Full Text] [Related]  

  • 140. Gene Editing for Duchenne Muscular Dystrophy Using the CRISPR/Cas9 Technology: The Importance of Fine-tuning the Approach.
    Tremblay JP; Iyombe-Engembe JP; Duchêne B; Ouellet DL
    Mol Ther; 2016 Nov; 24(11):1888-1889. PubMed ID: 27916992
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.